BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 14716495)

  • 1. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
    Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
    Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay.
    Lotspeich E; Schoene M; Gerngross H; Schmidt R; Steinmann R; Ramadani M; Gansauge S
    Langenbecks Arch Surg; 2007 Sep; 392(5):559-66. PubMed ID: 17457603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.
    Milsmann C; Füzesi L; Heinmöller E; Krause P; Werner C; Becker H; Horstmann O
    Langenbecks Arch Surg; 2008 Jan; 393(1):49-58. PubMed ID: 17876601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central mesenteric lymph node BER-Ep4+ cells in colorectal cancer: challenge to sentinel node concept?
    Schurr PG; Behnke S; Kaifi JT; Bogoevski D; Link B; Mann O; Strate T; Pantel K; Izbicki JR; Yekebas E
    Dig Surg; 2007; 24(1):19-27. PubMed ID: 17369677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of EpCAM-positive disseminated tumor cells in rectal cancer patients with stage I disease.
    Dhayat S; Sorescu S; Vallböhmer D; Kraus S; Baldus SE; Rehders A; Kröpil F; Krieg A; Knoefel WT; Stoecklein NH
    Am J Surg Pathol; 2012 Dec; 36(12):1809-16. PubMed ID: 23060348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.
    Izbicki JR; Hosch SB; Pichlmeier U; Rehders A; Busch C; Niendorf A; Passlick B; Broelsch CE; Pantel K
    N Engl J Med; 1997 Oct; 337(17):1188-94. PubMed ID: 9337377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.
    Broll R; Schauer V; Schimmelpenning H; Strik M; Woltmann A; Best R; Bruch HP; Duchrow M
    Dis Colon Rectum; 1997 Dec; 40(12):1465-71. PubMed ID: 9407986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer.
    Kubuschok B; Passlick B; Izbicki JR; Thetter O; Pantel K
    J Clin Oncol; 1999 Jan; 17(1):19-24. PubMed ID: 10458213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.
    Rosenberg R; Hoos A; Mueller J; Baier P; Stricker D; Werner M; Nekarda H; Siewert JR
    J Clin Oncol; 2002 Feb; 20(4):1049-55. PubMed ID: 11844829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression.
    Lassmann S; Bauer M; Rosenberg R; Nekarda H; Soong R; Rüger R; Höfler H; Werner M
    Int J Colorectal Dis; 2004 Mar; 19(2):87-94. PubMed ID: 13680284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAS.
    Oberg AN; Lindmark GE; Israelsson AC; Hammarström SG; Hammarström ML
    Int J Cancer; 2004 Aug; 111(1):101-10. PubMed ID: 15185350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer.
    Rosenberg R; Hoos A; Mueller J; Nekarda H
    Br J Cancer; 2000 Nov; 83(10):1323-9. PubMed ID: 11044357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
    Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
    J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
    Rashad Y; Olsson L; Israelsson A; Öberg Å; Lindmark G; Hammarström ML; Hammarström S; Sitohy B
    Tumour Biol; 2018 Sep; 40(9):1010428318799251. PubMed ID: 30198422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance.
    Hosch SB; Stoecklein NH; Pichlmeier U; Rehders A; Scheunemann P; Niendorf A; Knoefel WT; Izbicki JR
    J Clin Oncol; 2001 Apr; 19(7):1970-5. PubMed ID: 11283129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer.
    Passlick B; Izbicki JR; Kubuschok B; Nathrath W; Thetter O; Pichlmeier U; Schweiberer L; Riethmüller G; Pantel K
    J Clin Oncol; 1994 Sep; 12(9):1827-32. PubMed ID: 8083707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
    Ohlsson L; Israelsson A; Öberg Å; Palmqvist R; Stenlund H; Hammarström ML; Hammarström S; Lindmark G
    Int J Cancer; 2012 Apr; 130(8):1833-43. PubMed ID: 21618511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic importance of isolated peritumoral lymphangiosis carcinomatosa in lymph-node-negative colorectal carcinoma.
    Meyer W; Awad-Allah A; Steinhäuser BB; Jurowich C; Kaiser A; Gebhardt C
    Langenbecks Arch Surg; 2001 Mar; 386(2):124-31. PubMed ID: 11374045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma.
    Messerini L; Cianchi F; Cortesini C; Comin CE
    Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is minimal residual lymph node disease in papillary thyroid cancer of prognostic impact? An analysis of the epithelial cell adhesion molecule EpCAM in lymph nodes of 40 pN0 patients.
    Rehders A; Anlauf M; Adamowsky I; Ghadimi MH; Klein S; Antke C; Cupisti K; Stoecklein NH; Knoefel WT
    Pathol Oncol Res; 2014 Jan; 20(1):185-90. PubMed ID: 23918549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.